Chiron Unit Renamed Chiron Vaccines

22 September 1996

Chiron Corporation of the USA has changed the name of its vaccines business, Chiron Biocine, to Chiron Vaccines. The new name was launched at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy in New Orleans in the USA (for more on ICAAC see page 21).

"This has been a significant year of integration for Chiron Vaccines with the formation of our new joint venture Chiron Behring in Germany, and the strengthening of our vaccine business in Italy and emerging international markets," commented Dino Dina, president of Chiron Vaccines. "We feel the name change reinforces our goal of a single global business," he added.

Distribution Agreement Chiron has also announced a vaccines distribution agreement which it has reached with a group of affiliate companies that distribute pharmaceutical and vaccine products for major manufacturers to operate specialized distribution and sales functions for Chiron's vaccine products in the USA. The group is headed by General Injectables & Vaccines, and includes InSource Inc and Resolve Medical Marketing.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight